HK1249038A1 - 用ggf2 治療周圍神經損傷 - Google Patents

用ggf2 治療周圍神經損傷

Info

Publication number
HK1249038A1
HK1249038A1 HK18108829.0A HK18108829A HK1249038A1 HK 1249038 A1 HK1249038 A1 HK 1249038A1 HK 18108829 A HK18108829 A HK 18108829A HK 1249038 A1 HK1249038 A1 HK 1249038A1
Authority
HK
Hong Kong
Prior art keywords
ggf2
peripheral nerve
nerve injury
treat peripheral
treat
Prior art date
Application number
HK18108829.0A
Other languages
English (en)
Inventor
Anthony O Caggiano
Anthony J Bella
Anindita Ganguly
Jennifer Iaci
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of HK1249038A1 publication Critical patent/HK1249038A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK18108829.0A 2012-03-30 2018-07-09 用ggf2 治療周圍神經損傷 HK1249038A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693585P 2012-08-27 2012-08-27
US201261693589P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
HK1249038A1 true HK1249038A1 (zh) 2018-10-26

Family

ID=48128617

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15107369.1A HK1206632A1 (zh) 2012-03-30 2015-07-31 神經調節蛋白在治療外周神經損傷中的應用
HK18108829.0A HK1249038A1 (zh) 2012-03-30 2018-07-09 用ggf2 治療周圍神經損傷

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15107369.1A HK1206632A1 (zh) 2012-03-30 2015-07-31 神經調節蛋白在治療外周神經損傷中的應用

Country Status (16)

Country Link
US (3) US20150094263A1 (zh)
EP (3) EP2830645B1 (zh)
JP (4) JP6420233B2 (zh)
CN (2) CN104321072A (zh)
AU (4) AU2013237896B2 (zh)
BR (1) BR112014024308B1 (zh)
CA (1) CA2869070A1 (zh)
DK (2) DK2830645T3 (zh)
ES (2) ES2647917T3 (zh)
HK (2) HK1206632A1 (zh)
IL (3) IL288785B2 (zh)
MX (1) MX354598B (zh)
NZ (1) NZ700546A (zh)
PL (2) PL2830645T3 (zh)
PT (2) PT3278811T (zh)
WO (1) WO2013149163A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3338791T3 (da) 2008-07-17 2019-12-16 Acorda Therapeutics Inc Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt
US9078861B2 (en) 2009-10-14 2015-07-14 Acorda Therapeutics Inc. Use of a neuregulin to treat peripheral nerve injury
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
IL294038A (en) * 2015-12-04 2022-08-01 Univ Iowa Res Found Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium
CN111655336A (zh) 2017-11-17 2020-09-11 纽约州立大学研究基金会 使用x射线微束辐射治疗受损周围神经的方法
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
WO2021022254A2 (en) * 2019-08-01 2021-02-04 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
CA2306228A1 (en) * 1997-10-14 1999-04-22 Cambridge Neuroscience, Inc. Therapeutic methods comprising use of a neuregulin
ES2370875T3 (es) * 2000-05-23 2011-12-23 Acorda Therapeutics, Inc. Moléculas de ácido nucleico nrg-2, polipéptidos y métodos de diagnóstico y terapéuticos.
US20100286043A1 (en) * 2007-10-05 2010-11-11 Tufts Medical Center, Inc. Use of neuregulin-1 in reducing brain damage
AU2009217606B2 (en) * 2008-02-29 2015-03-05 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
DK3338791T3 (da) * 2008-07-17 2019-12-16 Acorda Therapeutics Inc Terapeutisk dosering af en neuregulin i behandling eller profylaxis af hjertesvigt
JP5826742B2 (ja) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド 神経損傷及び神経疾患の予防または治療用薬学組成物
US9078861B2 (en) * 2009-10-14 2015-07-14 Acorda Therapeutics Inc. Use of a neuregulin to treat peripheral nerve injury
CA2845198A1 (en) * 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
HK1206632A1 (zh) 2016-01-15
ES2857810T3 (es) 2021-09-29
US20160346353A1 (en) 2016-12-01
BR112014024308A2 (pt) 2017-08-08
JP2015514096A (ja) 2015-05-18
MX354598B (es) 2018-03-12
AU2013237896A1 (en) 2014-10-16
CN104321072A (zh) 2015-01-28
PL3278811T3 (pl) 2021-08-02
PT2830645T (pt) 2017-11-28
JP2017149746A (ja) 2017-08-31
PT3278811T (pt) 2021-03-03
AU2019202401A1 (en) 2019-05-02
EP2830645B1 (en) 2017-08-30
US20150094263A1 (en) 2015-04-02
AU2019202401B2 (en) 2020-10-15
JP2021059605A (ja) 2021-04-15
DK2830645T3 (da) 2017-11-20
WO2013149163A1 (en) 2013-10-03
AU2018200592A1 (en) 2018-02-15
IL273186A (en) 2020-04-30
PL2830645T3 (pl) 2018-01-31
EP3842059A1 (en) 2021-06-30
BR112014024308A8 (pt) 2018-01-23
JP7108724B2 (ja) 2022-07-28
IL288785B2 (en) 2023-03-01
IL234882A0 (en) 2014-12-31
JP2019131582A (ja) 2019-08-08
ES2647917T3 (es) 2017-12-27
AU2020260539A1 (en) 2020-11-26
CN106511971A (zh) 2017-03-22
AU2013237896B2 (en) 2017-11-02
JP6420233B2 (ja) 2018-11-07
IL288785A (en) 2022-02-01
IL234882B (en) 2020-03-31
EP2830645A1 (en) 2015-02-04
IL288785B (en) 2022-11-01
CA2869070A1 (en) 2013-10-03
NZ700546A (en) 2017-05-26
EP3278811A1 (en) 2018-02-07
US20230117985A1 (en) 2023-04-20
DK3278811T3 (da) 2021-03-01
IL273186B (en) 2022-01-01
BR112014024308B1 (pt) 2021-11-30
EP3278811B1 (en) 2020-12-02
MX2014011838A (es) 2015-03-09

Similar Documents

Publication Publication Date Title
HK1249038A1 (zh) 用ggf2 治療周圍神經損傷
IL266159A (en) Treatment of circadian rhythm disorders
HRP20180939T1 (hr) Kombinirana terapija za liječenje multiple skleroze
HK1210968A1 (zh) 用於眼部疾病和病症的組合物和治療
IL233714A0 (en) Treatment of diseases related to the circadian rhythm
GB201506561D0 (en) Treatment of amblyopia
EP2616094A4 (en) TREATMENT OF BRAIN INJURIES THROUGH IMPORTS
HK1204573A1 (zh) 炎性皮膚病症的治療
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
HK1210937A1 (zh) 匹多莫德治療銀屑病的用途
EP2882451A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF SUFFERING IN CONNECTION WITH LACK OF BLOOD SUPPLIES, SHOCKS AND INJURIES
EP2892612A4 (en) NONINVASIVE VAGUS NERVES TO TREAT DISORDER
GB201208505D0 (en) Treatment of skin condition